Vir Biotechnology
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.10-1.23-1.54-1.46
Price/Sales ratio
14.7710.202.672.33
Earnings per Share (EPS)
$-3.93$-3.52$-2.81$-2.96

Historical Multiples (2017 – 2023)

2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-19.45-11.72-7.75-10.6810.286.50-2.196.04-9.21
Price/Sales ratio
9.11K1.56K1.90K47.455.002.1215.651.9226.22
Price/Book Value ratio
-19.71-7.583.194.453.791.610.841.504.12
Price/Cash Flow ratio
-20.46-14.43-10.44-16.71-114.272.01-1.731.87-13.57
Price/Free Cash Flow ratio
-19.65-13.28-9.77-16.15-78.352.10-1.681.95-12.96
Price/Earnings Growth ratio
N/A-0.17-0.22-0.19-0.03-1.470.01-0.48-0.11
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-41854.36%-11447.11%-20782.13%-348.47%93.94%90.74%96.79%90.94%-10565.30%
Operating Profit Margin
-54695.97%-13674.19%-25032.20%-441.63%25.47%52.71%-794.04%51.55%-12736.92%
Pretax Profit Margin
-54212.08%-13405.99%-24546.97%-444.06%50.57%47.72%-728.93%46.68%-12495.52%
Net Profit Margin
-46880.53%-13350.69%-24568.63%-444.14%48.62%32.63%-713.69%31.92%-12506.39%
Effective Tax Rate
13.52%0.41%-0.08%-0.01%3.85%31.61%2.08%31.61%-0.05%
Return on Assets
-27.76%-60.48%-34.11%-32.50%27.04%18.40%-32.05%18.40%-33.31%
Return On Equity
101.35%64.67%-41.20%-41.66%36.91%24.82%-38.67%25.22%-41.43%
Return on Capital Employed
-34.08%-78.24%-39.30%-36.23%17.16%36.36%-39.24%36.36%-37.76%
Liquidity Ratios
Current Ratio
N/AN/A6.807.79N/AN/AN/A4.923.89
Quick Ratio
15.462.956.807.794.554.929.054.636.17
Cash ratio
15.101.191.844.401.011.661.451.662.71
Days of Sales Outstanding
N/AN/AN/AN/A259.57N/AN/AN/A129.78
Days of Inventory outstanding
N/AN/AN/AN/A47.62N/AN/AN/A23.81
Operating Cycle
N/AN/AN/AN/A307.19N/AN/AN/A153.59
Days of Payables Outstanding
28.5923.5714.456.1436.1316.01836.1316.0110.30
Cash Conversion Cycle
-28.59-23.57-14.45-6.14271.06-16.01-836.13-16.01132.45
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/A0.25N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/A0.34N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.05N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A85.70N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
-3.65-1.061.201.281.361.341.201.341.24
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-445.51-108.40-182.32-2.83-0.041.05-9.031.02-92.58
Free Cash Flow / Operating Cash Flow Ratio
1.041.081.061.031.450.951.020.951.24
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A